Therefore, immunotherapy using mRNA vaccines targeting previously recognized tumor antigens (AUNIP, FANCI, LASP1, PSMD8, and XPO5) could induce immune cell infiltration to reinvigorate the ISI patient’s immune system. The gene discussed is LASP1; the disease is neoplasm.